L. Borges

SN-38, the active metabolite of irinotecan, inhibits the acute inflammatory response by targeting toll-like receptor 4

F. Cunha, T. Cunha, A. Figueira, 2019, Cancer Chemotherapy and Pharmacology.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

Charles J. Vaske, Rohan N. Borkar, Brian D. Kelly, 2016, Journal of Immunotherapy for Cancer.

Effects of Palifermin on Antitumor Activity of Chemotherapeutic and Biological Agents in Human Head and Neck and Colorectal Carcinoma Xenograft Models

R. Radinsky, R. Brake, John Lu, 2008, Molecular Cancer Research.

Generation and characterization of monoclonal antibodies to human keratinocyte growth factor receptor.

P. Wei, T. Boone, D. Chang, 2006, Hybridoma.

Non-invasive detection of a palifermin-mediated adaptive response following chemotherapy-induced damage to the distal small intestine of rats

M. Geier, G. Davidson, G. Howarth, 2011, Cancer biology & therapy.

A protective role for keratinocyte growth factor in a murine model of chemotherapy and radiotherapy-induced mucositis.

K. Rex, P. Wei, S. Scully, 2006, International journal of radiation oncology, biology, physics.